From professional translators, enterprises, web pages and freely available translation repositories.
Средните (cv%)
cmax (mg/ l) - 0.50 (32%), cmin (mg/ l) - 0.19 (58%). lo in dvt and pe treatment, patients receiving fondaparinux 5 mg (body weight 100 kg) once daily, the body weight-adjusted no
Средни (% cv) фармакокинетични параметри при многократно приложение на
mean (% cv) multiple-dose pharmacokinetic parameters for viraferon and ribavirin capsules when administered to children or adolescents with chronic hepatitis c
Оценените средни (cv%) фармакокинетични параметри на фондапаринукс в стационарно
20 mean (cv%) steady state pharmacokinetic parameters estimates of fondaparinux in patients undergoing hip replacement surgery receiving fondaparinux 2.5 mg once daily are: